How many patents does
Incyte have?
patents
2,808
families
202
granted
673
applications
2,135
US
614
EP
213
WO
144
JP
115
CN
115
KR
86
RoW
1,521
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Incyte
Top ten assignees appearing on patents
2009 - 2018
2009
| incyte | 98 |
| insajt korporejshn | 2 |
| pharmasset | 1 |
2018
| incyte | 244 |
| incyte holdings corporation | 147 |
| novartis pharmaceuticals | 2 |
Incyte
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus ki… 🛈 | 156 | 2005 |
| 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | 89 | 2008 |
| piperidin-4-yl azetidine derivatives as jak1 inhibitors | 74 | 2010 |
| processes for preparing jak inhibitors and related intermediate compounds | 73 | 2009 |
| salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazo… 🛈 | 69 | 2007 |
| heterocyclylamines as pi3k inhibitors | 67 | 2011 |
| imidazotriazines and imidazopyrimidines as kinase inhibitors | 63 | 2006 |
| azetidine and cyclobutane derivatives as jak inhibitors | 58 | 2008 |
| substituted tricyclic compounds as fgfr inhibitors | 56 | 2012 |
| modulators of indoleamine 2,3-dioxygenase and methods of using the same | 55 | 2005 |